Manchester first to adopt Congenicas SapientiaTM technology
Back Manchester first to adopt Congenicas SapientiaTM technology 10,000 new patients a year are treated by the Manchester Centre for Genomic Medicine (MCGM) for a range of rare diseases including cancers, developmental disorders and disabilities including hearing and vision loss – diagnosis can be time- consuming and invasive. This is set to change as Manchester …
Manchester first to adopt Congenicas SapientiaTM technology Read More »